Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Grez

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Pain|December 17, 2013
Prostacyclin mediates neuropathic pain through interleukin 1β-expressing resident macrophagesClaus Dieter Schuh, Sandra Pierre, Andreas Weigert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosisMaria Chiriaco, Giada Farinelli, Valentina Capo, et al.
Oncotarget|April 17, 2017
Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancerHelga Weber, José R Valbuena, Mustafa A Barbhuiya, et al.
Cell|February 22, 2011
DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramerGregor B Deutsch, Elisabeth M Zielonka, Daniel Coutandin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2014
Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptorKurt Schönfeld, Christiane Sahm, Congcong Zhang, et al.
Current Gene Therapy|May 19, 2015
Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of TimingUlrich Siler, Anna Paruzynski, Heidi Holtgreve-Grez, et al.
Nature Medicine|April 4, 2006
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Marion G Ott, Manfred Schmidt, Kerstin Schwarzwaelder, et al.
Nature Medicine|January 26, 2010
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous diseaseStefan Stein, Marion G Ott, Stephan Schultze-Strasser, et al.
Human Gene Therapy. Clinical Development|July 13, 2013
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous diseaseStefan Stein, Simone Scholz, Joachim Schwäble, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapyAnnette Deichmann, Martijn H Brugman, Cynthia C Bartholomae, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Pain|December 17, 2013
Prostacyclin mediates neuropathic pain through interleukin 1β-expressing resident macrophagesClaus Dieter Schuh, Sandra Pierre, Andreas Weigert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosisMaria Chiriaco, Giada Farinelli, Valentina Capo, et al.
Oncotarget|April 17, 2017
Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancerHelga Weber, José R Valbuena, Mustafa A Barbhuiya, et al.
Cell|February 22, 2011
DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramerGregor B Deutsch, Elisabeth M Zielonka, Daniel Coutandin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2014
Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptorKurt Schönfeld, Christiane Sahm, Congcong Zhang, et al.
Current Gene Therapy|May 19, 2015
Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of TimingUlrich Siler, Anna Paruzynski, Heidi Holtgreve-Grez, et al.
Nature Medicine|April 4, 2006
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Marion G Ott, Manfred Schmidt, Kerstin Schwarzwaelder, et al.
Nature Medicine|January 26, 2010
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous diseaseStefan Stein, Marion G Ott, Stephan Schultze-Strasser, et al.
Human Gene Therapy. Clinical Development|July 13, 2013
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous diseaseStefan Stein, Simone Scholz, Joachim Schwäble, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapyAnnette Deichmann, Martijn H Brugman, Cynthia C Bartholomae, et al.
Pageof 8